BMC Clinical Pharmacology

Table 2 Number of individuals with polypharmacy, and excessive polypharmacy

From: Increasing polypharmacy - an individual-based study of the Swedish population 2005-2008

Age group	DP≥5				DP≥10
	2005	2006	2007	2008	2005	2006	2007	2008
0-9	4,698	4,829	4,529	4,653	243	235	246	230
10-19	9,082	8,974	9,300	9,693	579	578	574	620
20-29	17,598	17,993	18,481	18,930	1,486	1,598	1,601	1,646
30-39	35,926	36,118	35,857	36,297	4,129	4,312	4,230	4,345
40-49	64,044	66,952	69,170	70,883	9,666	10,058	10,730	10,919
50-59	137,191	137,651	138,873	139,519	22,785	23,587	23,763	24,142
60-69	191,510	205,066	220,723	234,603	36,053	39,159	42,206	44,942
70-79	231,413	236,654	242,252	250,348	51,575	54,790	56,488	58,788
80-89	195,172	203,814	208,939	213,207	49,833	57,490	59,282	61,060
90-	36,315	39,228	39,985	41,191	9,269	11,884	12,197	12,552
Total	922,949	957,279	988,109	1,019,324	185,618	203,691	211,317	219,244

Number of individuals with polypharmacy (DP≥5), and excessive polypharmacy (DP≥10) in different age groups in Sweden 2005-2008.

Back to article page